Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Surg Endosc. 2019 Feb 6;33(10):3404–3411. doi: 10.1007/s00464-018-06636-3

Table 3:

Adverse Events

EUS-GE (n, %) Enteral Stent (n, %) p value
Total Adverse Events 5 (20.8) 39 (40.2) 0.098
Stent Ingrowth 1 (4.2) 16 (16.5) 0.189
Stent Obstruction (not including ingrowth) 0 (0.0) 7 (7.2) 0.342
Stent Migration 0 (0.0) 2 (2.1) 1.000
Inadequate Stent Length 0 (0.0) 2 (2.1) 1.000
Bleeding 0 (0.0) 1 (1.0) 1.000
Biliary Obstruction 0 (0.0) 2 (2.1) 1.000
PEG Placement 1 (4.2) 5 (5.2) 1.000
Conversion to EUS-GE (enteral stent only) --- 1 (1.0) ---
LAMS Mesh Erosion (EUS-GE only) 1 (4.2) --- ---
LAMS Misdeployment (EUS-GE only) 2 (8.3) --- ---
Death Within 30 Days 0 (0.0) 3 (3.1) 1.000

Abbreviations:

EUS = endoscopic ultrasound

GE = gastroenterostomy